Vanda Pharmaceuticals (VNDA) Tax Rate Growth (1y) (2011 - 2026)
Vanda Pharmaceuticals (VNDA) Tax Rate Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Vanda Pharmaceuticals | 310.98 Mn | 108.67 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,128.00 |
| Dec 31, 2025 | -29,648.00 |
| Sep 30, 2025 | 602.00 |
| Jun 30, 2025 | 398.00 |
| Mar 31, 2025 | 997.00 |
| Dec 31, 2024 | 6,890.00 |
| Sep 30, 2024 | -19,975.00 |
| Jun 30, 2024 | -2,435.00 |
| Mar 31, 2024 | -3,050.00 |
| Dec 31, 2023 | -7,258.00 |
| Sep 30, 2023 | 17,388.00 |
| Jun 30, 2023 | 1,078.00 |
| Mar 31, 2023 | 2,706.00 |
| Dec 31, 2022 | 1,083.00 |
| Sep 30, 2022 | 1,231.00 |
| Jun 30, 2022 | 825.00 |
| Mar 31, 2022 | -251.00 |
| Dec 31, 2021 | -709.00 |
| Sep 30, 2021 | -123.00 |
| Jun 30, 2021 | 177.00 |